By Susanna Jeurling
Peer Reviewed
The U.S. Preventive Services Task Force (USPSTF) recently finalized its position regarding annual low-dose computed tomography (LDCT) scanning for early detection of lung cancer. The grade B recommendation …
Clinical Correlations
The NYU Langone Health Online Journal of Medicine
Infection Transmission During Air Travel
May 7, 2014
By Aaron Smith, MD
Peer Reviewed
It’s become a familiar site to travelers: airline passengers wearing respiratory masks to filter pathogens from the cabin air. To those not wearing masks, the fashion trend …
Primecuts – This Week In The Journals
May 5, 2014
By Jennifer Ng, MD
Peer Reviewed
The end is near, as has been foretold for over a thousand years. Yet, the plague, Halley’s comet, Nostradamus, Y2K, and the Mayan Prophecy – just to name a few so-called predicted apocalyptic events …
Is the Funduscopic Exam Worthwhile For the General Practitioner?
May 2, 2014
By Emily Fisher
Peer Reviewed
Some have said that physical examination is a dying art and the nondilated funduscopic exam may be one of the best examples of this. …
Clinical Correlations Reaches 1000 Articles Published!!
May 1, 2014
By: Neil Shapiro, MD Editor in Chief, Clinical Correlations
It’s so hard to fathom that Clinical Correlations, now in its 8th year, has reached yet another very significant milestone – 1000 …
MSG: Can an Amino Acid Really Be Harmful?
April 30, 2014
By Michael Lee, MD
Peer Reviewed
The human taste bud has become increasingly accustomed to the Japanese invention of the early 20th century: monosodium glutamate, better known as MSG. Its basic component, …
Primecuts – This Week In The Journals
April 28, 2014
By Nicole Van Groningen, MD
Peer reviewed
NYU Langone made headlines in the New York Times this week with the re-opening of its emergency room, over 18 months after waters from the East River flooded the hospital during Hurricane Sandy [1]. …
Direct-to-Consumer Genetic Testing: Impact on Patients and Preventive Medicine
April 25, 2014
By Neelesh Rastogi
Peer Reviewed
In reference to the $100,000 he spent to research the genetic basis of the pancreatic cancer that ultimately killed him, Steve Jobs famously said, “I’m either going …